1606 Corp の最大収益セグメントは Stereopure Oligonucleotides で、最新の利益発表における収益は 113,305,000 です。地域別に見ると、Singapore, United States, Japan, United Kingdom, and Ireland が 1606 Corp の主要市場であり、収益は 113,305,000 です。
1606 Corpは収益を上げていますか?
いいえ、最新の財務諸表によると、1606 Corpの純損失は$0です。
1606 Corpに負債はありますか?
いいえ、1606 Corpの負債は0です。
1606 Corpの発行済株式数は何株ですか?
1606 Corpの総発行済株式数は0株です。
主要データ
前終値
$0.0001
始値
$0.0001
当日レンジ
$0.0001 - $0.0002
52週レンジ
$0.0001 - $0.0032
取引高
--
平均取引高
22.1M
配当利回り
--
1株当たり利益(TTM)
-0.01
時価総額
$151.0K
CBDWとは何ですか?
1606 Corp. manufactures tobacco products. The company is headquartered in Phoenix, Arizona and currently employs 1 full-time employees. The company went IPO on 2023-01-12. The firm specializes in building and merchandizing AI Chatbots for the cannabidiol (CBD) industry and AI Chatbots for public companies. ChatCBDW chatbot offers CBD and wellness merchants the ability to improve sales by providing product recommendations, track user behavior for inventory management, and ChatCBDW can also provide information on products and education around the clock. ChatCBDW is a proprietary bot fully integrated with ChatGPT, a language model developed by OpenAI. This integration equips ChatCBDW with natural language processing (NLP) and machine learning capabilities, allowing lifelike conversations and intelligent product recommendations. IRChat is a chatbot that is able to go on a public company’s website and pull-down vital information for investors and shareholders. Examples of this vital information include SEC filings, company updates and press releases, and others.